NCT04065815 (PROTECT) is a NA clinical trial of Resistance Training in Cancer, sponsored by University of Erlangen-Nürnberg Medical School.

Who is sponsoring NCT04065815?

NCT04065815 is sponsored by University of Erlangen-Nürnberg Medical School.

What drugs are being tested in NCT04065815?

Interventions in NCT04065815: Resistance Training, WB-EMS, High-intensity interval training (HIIT), Combined HIIT and Resistance Training (Combi).

What condition does NCT04065815 study?

NCT04065815 studies Cancer, Cancer Cachexia, Inflammation.

Is NCT04065815 still recruiting?

NCT04065815 is currently status unknown. Last updated 22 August 2019.

Last reviewed 2019-08-22 · How we verify

NCT04065815: PROTECT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Protein-rich Nutritional Therapy Combined With Time-efficient Exercise in Cancer Therapy

Status unknown NA Last updated 22 August 2019

What this trial tests

NA trial testing Resistance Training in Cancer in 100 participants. Status unknown.

Timeline

1 May 2019

Primary endpoint
31 March 2022

31 March 2022

Quick facts

Lead sponsor	University of Erlangen-Nürnberg Medical School
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 May 2019
Primary completion	31 March 2022
Estimated completion	31 March 2022
Sites	1 location across Germany

Drugs / interventions tested

Resistance Training
WB-EMS
High-intensity interval training (HIIT)
Combined HIIT and Resistance Training (Combi)

Conditions studied

Cancer — all drugs for Cancer →
Cancer Cachexia — all drugs for Cancer Cachexia →
Inflammation — all drugs for Inflammation →

Sponsor

University of Erlangen-Nürnberg Medical School

Who can join

18 and older, any sex, with Cancer or Cancer Cachexia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the effects of a 12-week protein-rich individualized nutritional therapy combined with different time-efficient exercise programs on overall physical fitness (cardiorespiratory fitness and muscular fitness), inflammation, and muscle mass/body composition in patients with malignant disease undergoing curative or palliative anti-cancer treatment

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Feasibility, Safety, and Preliminary Efficacy of Very Low-Volume Interval Training in Advanced Cancer Patients.
Reljic D, Herrmann HJ, Jakobs B, Dieterich W, et al · · 2022 · cited 18× · PMID 35868017 · DOI 10.1249/mss.0000000000002989

Verify or expand the search:

Other trials of Resistance Training

Trials testing the same drug.

NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
NCT07278440 — An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregi · NA · not yet recruiting
NCT07364149 — Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metaboli · NA · recruiting
NCT07262931 — Effect Of Sensory Motor Training Versus Resistance Training Among Individuals With Knee Osteoarthritis. · NA · not yet recruiting
NCT07045727 — Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Olde · NA · recruiting

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other University of Erlangen-Nürnberg Medical School trials

Trials by the same sponsor.

NCT06969820 — Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT · not yet recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07352540 — Single vs Triple Hyaluronic Acid in Knee Osteoarthritis · Phase 2, PHASE3 · not yet recruiting
NCT07313878 — Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Micros · NA · recruiting
NCT07121985 — Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré S · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04065815 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg Medical School
Last refreshed: 22 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04065815.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing